1. Home
  2. STRO vs DBI Comparison

STRO vs DBI Comparison

Compare STRO & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$13.70

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Logo Designer Brands Inc.

DBI

Designer Brands Inc.

HOLD

Current Price

$7.73

Market Cap

138.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRO
DBI
Founded
2003
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
85.0M
138.7M
IPO Year
2018
1991

Fundamental Metrics

Financial Performance
Metric
STRO
DBI
Price
$13.70
$7.73
Analyst Decision
Hold
Hold
Analyst Count
8
2
Target Price
$18.29
$7.25
AVG Volume (30 Days)
122.6K
1.0M
Earning Date
11-06-2025
12-09-2025
Dividend Yield
N/A
2.58%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$105,646,000.00
$2,892,654,000.00
Revenue This Year
$63.08
N/A
Revenue Next Year
N/A
$2.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.23
$2.18
52 Week High
$21.50
$8.75

Technical Indicators

Market Signals
Indicator
STRO
DBI
Relative Strength Index (RSI) 73.77 55.79
Support Level $10.52 $7.18
Resistance Level $13.30 $8.35
Average True Range (ATR) 1.14 0.55
MACD -0.07 -0.12
Stochastic Oscillator 91.75 50.37

Price Performance

Historical Comparison
STRO
DBI

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About DBI Designer Brands Inc.

Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.

Share on Social Networks: